

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.80216022 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.15480365 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.15480365 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.90978886 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.85415114 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.79865337 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.77705192 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.75971937 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.53736861 |
| 10 | negative thymic T cell selection (GO:0045060) | 4.41518925 |
| 11 | negative T cell selection (GO:0043383) | 4.39219097 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.32868653 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.16493963 |
| 14 | response to interleukin-15 (GO:0070672) | 3.93302706 |
| 15 | positive thymic T cell selection (GO:0045059) | 3.88660408 |
| 16 | cellular response to interleukin-15 (GO:0071350) | 3.86250080 |
| 17 | T cell migration (GO:0072678) | 3.78079313 |
| 18 | negative regulation of T cell mediated immunity (GO:0002710) | 3.72098812 |
| 19 | response to type I interferon (GO:0034340) | 3.70549706 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 3.69903974 |
| 21 | type I interferon signaling pathway (GO:0060337) | 3.69200869 |
| 22 | cellular response to type I interferon (GO:0071357) | 3.69200869 |
| 23 | positive T cell selection (GO:0043368) | 3.67936630 |
| 24 | regulation of B cell differentiation (GO:0045577) | 3.63976591 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 3.58307056 |
| 26 | B cell receptor signaling pathway (GO:0050853) | 3.58076250 |
| 27 | positive regulation of defense response to virus by host (GO:0002230) | 3.56234867 |
| 28 | leukocyte aggregation (GO:0070486) | 3.52591384 |
| 29 | tolerance induction (GO:0002507) | 3.52095928 |
| 30 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.51817039 |
| 31 | T cell selection (GO:0045058) | 3.50443721 |
| 32 | interferon-gamma production (GO:0032609) | 3.49966998 |
| 33 | positive regulation of granulocyte differentiation (GO:0030854) | 3.48518110 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.43249415 |
| 35 | thymic T cell selection (GO:0045061) | 3.41722713 |
| 36 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.41229788 |
| 37 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.39931105 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 3.38075738 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.34190792 |
| 40 | activated T cell proliferation (GO:0050798) | 3.31684687 |
| 41 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.30585117 |
| 42 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.29552706 |
| 43 | regulation of regulatory T cell differentiation (GO:0045589) | 3.28544704 |
| 44 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.28198591 |
| 45 | regulation of antigen processing and presentation (GO:0002577) | 3.23744353 |
| 46 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.19422326 |
| 47 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.17987385 |
| 48 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.17987385 |
| 49 | positive regulation of antigen processing and presentation (GO:0002579) | 3.17649173 |
| 50 | mast cell activation (GO:0045576) | 3.15713004 |
| 51 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.15372225 |
| 52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.14456029 |
| 53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.14456029 |
| 54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.14456029 |
| 55 | modulation by symbiont of host immune response (GO:0052553) | 3.14456029 |
| 56 | positive regulation by symbiont of host defense response (GO:0052509) | 3.14456029 |
| 57 | modulation by symbiont of host defense response (GO:0052031) | 3.14456029 |
| 58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.14272113 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.13995138 |
| 60 | defense response to protozoan (GO:0042832) | 3.13287595 |
| 61 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.07364315 |
| 62 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.06065193 |
| 63 | regulation of T cell tolerance induction (GO:0002664) | 3.02297110 |
| 64 | detection of bacterium (GO:0016045) | 2.98063355 |
| 65 | detection of other organism (GO:0098543) | 2.95544662 |
| 66 | response to interferon-beta (GO:0035456) | 2.95368200 |
| 67 | cellular response to exogenous dsRNA (GO:0071360) | 2.95079643 |
| 68 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.94353876 |
| 69 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.94158020 |
| 70 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.90340740 |
| 71 | response to protozoan (GO:0001562) | 2.89761873 |
| 72 | regulation of cell killing (GO:0031341) | 2.89651308 |
| 73 | T cell receptor signaling pathway (GO:0050852) | 2.89618444 |
| 74 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.89404386 |
| 75 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.89278699 |
| 76 | cytidine metabolic process (GO:0046087) | 2.88528749 |
| 77 | cytidine catabolic process (GO:0006216) | 2.88528749 |
| 78 | cytidine deamination (GO:0009972) | 2.88528749 |
| 79 | actin nucleation (GO:0045010) | 2.87273043 |
| 80 | B cell mediated immunity (GO:0019724) | 2.85456694 |
| 81 | negative regulation of innate immune response (GO:0045824) | 2.85093284 |
| 82 | positive regulation of DNA recombination (GO:0045911) | 2.84493274 |
| 83 | positive regulation of isotype switching (GO:0045830) | 2.82863963 |
| 84 | neutrophil activation involved in immune response (GO:0002283) | 2.82861879 |
| 85 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.82325689 |
| 86 | negative regulation of viral genome replication (GO:0045071) | 2.80434019 |
| 87 | regulation of tolerance induction (GO:0002643) | 2.79978367 |
| 88 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.79473440 |
| 89 | positive regulation of tolerance induction (GO:0002645) | 2.79218911 |
| 90 | NIK/NF-kappaB signaling (GO:0038061) | 2.78795994 |
| 91 | DNA deamination (GO:0045006) | 2.78738278 |
| 92 | interferon-gamma secretion (GO:0072643) | 2.78485393 |
| 93 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.78370840 |
| 94 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.76961862 |
| 95 | regulation of defense response to virus by host (GO:0050691) | 2.76882195 |
| 96 | regulation of interferon-alpha production (GO:0032647) | 2.76387909 |
| 97 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.75651592 |
| 98 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.75032774 |
| 99 | macrophage activation involved in immune response (GO:0002281) | 2.74710389 |
| 100 | mast cell activation involved in immune response (GO:0002279) | 2.73772078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.42059993 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.06657910 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.80710600 |
| 4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.43052172 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.92108391 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.56729422 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.23898286 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.08041956 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07312084 |
| 10 | * MYB_26560356_Chip-Seq_TH2_Human | 2.93893182 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67931054 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.67336590 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.61367123 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.55181598 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44401736 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.38752353 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33234908 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.29663044 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27782950 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.23796784 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.21493488 |
| 22 | GATA3_26560356_Chip-Seq_TH2_Human | 2.09288154 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.08195799 |
| 24 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.05730510 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04292136 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00354083 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.99271372 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.95916864 |
| 29 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88147971 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84192219 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76173627 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75713839 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73259838 |
| 34 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64433467 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61047715 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60545071 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.58177158 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56904796 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54332581 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53193261 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53120418 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51914724 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50385565 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44918312 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42313381 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.38786757 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32397312 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24368164 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24244754 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.19222837 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17201557 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17156932 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12021831 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12015458 |
| 55 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09111278 |
| 56 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08206256 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06827801 |
| 58 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05235617 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04704508 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03776458 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02892745 |
| 62 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01955296 |
| 63 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.00993470 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99706088 |
| 65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99660744 |
| 66 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.96231570 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95723218 |
| 68 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95340140 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94605173 |
| 70 | P300_27268052_Chip-Seq_Bcells_Human | 0.93357453 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92600962 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92294798 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.91397460 |
| 74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90731394 |
| 75 | GATA3_26560356_Chip-Seq_TH1_Human | 0.90159767 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89271200 |
| 77 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89120277 |
| 78 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88269129 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86953653 |
| 80 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85737280 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84794995 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.84400437 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83674046 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83368790 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82004497 |
| 86 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81081657 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80788475 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80635198 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79762793 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77915002 |
| 91 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.77789717 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77285268 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75284713 |
| 94 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73583708 |
| 95 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.72387462 |
| 96 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71569843 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69875717 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69077751 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68391351 |
| 100 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.68353766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.13471258 |
| 2 | MP0005671_abnormal_response_to | 3.78492154 |
| 3 | MP0003724_increased_susceptibility_to | 3.58023394 |
| 4 | MP0003436_decreased_susceptibility_to | 3.33005966 |
| 5 | MP0001800_abnormal_humoral_immune | 3.30769950 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.20405981 |
| 7 | MP0000685_abnormal_immune_system | 3.13075482 |
| 8 | MP0009785_altered_susceptibility_to | 3.09299586 |
| 9 | MP0001790_abnormal_immune_system | 3.08551436 |
| 10 | MP0005387_immune_system_phenotype | 3.08551436 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.08013606 |
| 12 | MP0002723_abnormal_immune_serum | 2.81875475 |
| 13 | MP0005025_abnormal_response_to | 2.70646958 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.69198309 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.66014654 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.59562932 |
| 17 | MP0001819_abnormal_immune_cell | 2.57039870 |
| 18 | MP0006082_CNS_inflammation | 2.55341053 |
| 19 | MP0002419_abnormal_innate_immunity | 2.49806989 |
| 20 | MP0003303_peritoneal_inflammation | 2.34160494 |
| 21 | MP0002405_respiratory_system_inflammati | 2.15577378 |
| 22 | MP0002398_abnormal_bone_marrow | 2.08778880 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.07939139 |
| 24 | MP0000716_abnormal_immune_system | 2.03054867 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.00781964 |
| 26 | MP0001873_stomach_inflammation | 1.84292664 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.84099065 |
| 28 | MP0000689_abnormal_spleen_morphology | 1.83403344 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.78707657 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.76369592 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.71537811 |
| 32 | MP0002722_abnormal_immune_system | 1.71129723 |
| 33 | MP0003866_abnormal_defecation | 1.70702757 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.69538199 |
| 35 | MP0009764_decreased_sensitivity_to | 1.65270686 |
| 36 | MP0004947_skin_inflammation | 1.62849625 |
| 37 | MP0002429_abnormal_blood_cell | 1.59791573 |
| 38 | MP0005310_abnormal_salivary_gland | 1.57879587 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.55172640 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.53341139 |
| 41 | MP0008469_abnormal_protein_level | 1.52196202 |
| 42 | MP0002933_joint_inflammation | 1.31885710 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.31854949 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.28517735 |
| 45 | MP0002132_abnormal_respiratory_system | 1.27271020 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.19645394 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.19320132 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.18075159 |
| 49 | MP0004381_abnormal_hair_follicle | 1.17477218 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.15206634 |
| 51 | MP0002006_tumorigenesis | 1.12985273 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.11950014 |
| 53 | MP0003252_abnormal_bile_duct | 1.11671638 |
| 54 | MP0009278_abnormal_bone_marrow | 1.09860606 |
| 55 | MP0001853_heart_inflammation | 1.08875718 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.08089369 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.08089369 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.02425576 |
| 59 | MP0000858_altered_metastatic_potential | 0.98535492 |
| 60 | MP0003195_calcinosis | 0.97454637 |
| 61 | MP0001663_abnormal_digestive_system | 0.97276281 |
| 62 | MP0003045_fibrosis | 0.97228601 |
| 63 | MP0009763_increased_sensitivity_to | 0.94230346 |
| 64 | MP0001851_eye_inflammation | 0.93554236 |
| 65 | MP0004883_abnormal_blood_vessel | 0.91467176 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 0.89849614 |
| 67 | MP0005451_abnormal_body_composition | 0.84631152 |
| 68 | MP0002998_abnormal_bone_remodeling | 0.83776703 |
| 69 | MP0002876_abnormal_thyroid_physiology | 0.82589838 |
| 70 | MP0004808_abnormal_hematopoietic_stem | 0.81599529 |
| 71 | MP0005164_abnormal_response_to | 0.81313376 |
| 72 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80653224 |
| 73 | MP0003828_pulmonary_edema | 0.76065855 |
| 74 | MP0000569_abnormal_digit_pigmentation | 0.75119891 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.74926021 |
| 76 | MP0003448_altered_tumor_morphology | 0.72038479 |
| 77 | MP0005390_skeleton_phenotype | 0.71684129 |
| 78 | MP0002019_abnormal_tumor_incidence | 0.71042722 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.70696932 |
| 80 | MP0002163_abnormal_gland_morphology | 0.69908409 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.68970411 |
| 82 | MP0000249_abnormal_blood_vessel | 0.68910874 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.67545254 |
| 84 | MP0001501_abnormal_sleep_pattern | 0.66838266 |
| 85 | MP0005360_urolithiasis | 0.65891899 |
| 86 | MP0002254_reproductive_system_inflammat | 0.65796896 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.65084350 |
| 88 | MP0008877_abnormal_DNA_methylation | 0.64807328 |
| 89 | MP0005166_decreased_susceptibility_to | 0.64476449 |
| 90 | MP0005174_abnormal_tail_pigmentation | 0.63256468 |
| 91 | MP0000604_amyloidosis | 0.61773163 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.59248238 |
| 93 | MP0009840_abnormal_foam_cell | 0.58642253 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.58356974 |
| 95 | MP0000609_abnormal_liver_physiology | 0.57801844 |
| 96 | MP0003646_muscle_fatigue | 0.57747704 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.57038689 |
| 98 | MP0001764_abnormal_homeostasis | 0.55428677 |
| 99 | MP0003075_altered_response_to | 0.54332881 |
| 100 | MP0009643_abnormal_urine_homeostasis | 0.54003176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.07115450 |
| 2 | Myositis (HP:0100614) | 4.85594355 |
| 3 | Stomatitis (HP:0010280) | 4.85105022 |
| 4 | T lymphocytopenia (HP:0005403) | 4.63105269 |
| 5 | Abnormality of T cell number (HP:0011839) | 4.58714120 |
| 6 | Optic neuritis (HP:0100653) | 4.52051392 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.52051392 |
| 8 | Orchitis (HP:0100796) | 4.37904680 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.15610234 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.11243168 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.90509149 |
| 12 | Abnormality of T cells (HP:0002843) | 3.89509290 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.80120950 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.75926237 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.72316863 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.72316863 |
| 17 | Meningitis (HP:0001287) | 3.65834225 |
| 18 | Vasculitis (HP:0002633) | 3.63941542 |
| 19 | Pustule (HP:0200039) | 3.62872098 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 3.60528299 |
| 21 | IgG deficiency (HP:0004315) | 3.58282700 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.57859443 |
| 23 | Encephalitis (HP:0002383) | 3.57028571 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.54943487 |
| 25 | Pulmonary infiltrates (HP:0002113) | 3.54077752 |
| 26 | Recurrent viral infections (HP:0004429) | 3.49791289 |
| 27 | Severe combined immunodeficiency (HP:0004430) | 3.44992983 |
| 28 | Agammaglobulinemia (HP:0004432) | 3.41876236 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 3.32902363 |
| 30 | Abnormality of macrophages (HP:0004311) | 3.31855755 |
| 31 | Increased IgM level (HP:0003496) | 3.30751356 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 3.29749855 |
| 33 | Keratoconjunctivitis (HP:0001096) | 3.13211041 |
| 34 | Hemoptysis (HP:0002105) | 3.11922802 |
| 35 | Recurrent skin infections (HP:0001581) | 3.11693303 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 3.09445324 |
| 37 | Recurrent bronchitis (HP:0002837) | 3.09146577 |
| 38 | Leukocytosis (HP:0001974) | 3.05583643 |
| 39 | Obstructive lung disease (HP:0006536) | 3.04725670 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 3.04725670 |
| 41 | Abnormality of eosinophils (HP:0001879) | 3.04599381 |
| 42 | Eosinophilia (HP:0001880) | 3.02611120 |
| 43 | Granulocytopenia (HP:0001913) | 3.01235150 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.91669972 |
| 45 | Abnormality of B cell number (HP:0010975) | 2.87796600 |
| 46 | Abnormality of the prostate (HP:0008775) | 2.75369563 |
| 47 | Chronic diarrhea (HP:0002028) | 2.74028750 |
| 48 | Chest pain (HP:0100749) | 2.68779869 |
| 49 | Combined immunodeficiency (HP:0005387) | 2.64370693 |
| 50 | Arterial thrombosis (HP:0004420) | 2.63996548 |
| 51 | Prolonged bleeding time (HP:0003010) | 2.63642440 |
| 52 | Thyroiditis (HP:0100646) | 2.56158114 |
| 53 | Lymphopenia (HP:0001888) | 2.51670589 |
| 54 | Anorexia (HP:0002039) | 2.51335769 |
| 55 | Hypergammaglobulinemia (HP:0010702) | 2.46976041 |
| 56 | Abnormality of the pleura (HP:0002103) | 2.42836472 |
| 57 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.41601246 |
| 58 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40468257 |
| 59 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40468257 |
| 60 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40468257 |
| 61 | Pulmonary embolism (HP:0002204) | 2.40030434 |
| 62 | Epistaxis (HP:0000421) | 2.38539603 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.37192104 |
| 64 | Gangrene (HP:0100758) | 2.37006606 |
| 65 | Urticaria (HP:0001025) | 2.35878830 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.33751153 |
| 67 | Joint swelling (HP:0001386) | 2.30873825 |
| 68 | B lymphocytopenia (HP:0010976) | 2.30824268 |
| 69 | Gingival bleeding (HP:0000225) | 2.30571766 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.26791173 |
| 71 | Chronic otitis media (HP:0000389) | 2.24393514 |
| 72 | Papilloma (HP:0012740) | 2.22580561 |
| 73 | Verrucae (HP:0200043) | 2.22580561 |
| 74 | Keratitis (HP:0000491) | 2.21478795 |
| 75 | Recurrent sinusitis (HP:0011108) | 2.19107987 |
| 76 | Alveolar cell carcinoma (HP:0006519) | 2.18391740 |
| 77 | Increased IgE level (HP:0003212) | 2.15723397 |
| 78 | Stomach cancer (HP:0012126) | 2.11830954 |
| 79 | Acute hepatic failure (HP:0006554) | 2.11825399 |
| 80 | Polyneuropathy (HP:0001271) | 2.11775980 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.11198854 |
| 82 | Gastrointestinal stroma tumor (HP:0100723) | 2.09757745 |
| 83 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.07657226 |
| 84 | Hypochromic anemia (HP:0001931) | 2.07022390 |
| 85 | Increased serum ferritin (HP:0003281) | 2.05155087 |
| 86 | IgM deficiency (HP:0002850) | 2.04498031 |
| 87 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.02510525 |
| 88 | Congenital stationary night blindness (HP:0007642) | 2.00804463 |
| 89 | Skin rash (HP:0000988) | 2.00588791 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 1.99353663 |
| 91 | Prostate neoplasm (HP:0100787) | 1.97679107 |
| 92 | Hypoproteinemia (HP:0003075) | 1.97292916 |
| 93 | Gingivitis (HP:0000230) | 1.94610251 |
| 94 | Abnormality of the pericardium (HP:0001697) | 1.94553689 |
| 95 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94542656 |
| 96 | Glomerulopathy (HP:0100820) | 1.92308111 |
| 97 | Vacuolated lymphocytes (HP:0001922) | 1.89739302 |
| 98 | Cellulitis (HP:0100658) | 1.89331025 |
| 99 | IgA deficiency (HP:0002720) | 1.89244459 |
| 100 | Episodic fever (HP:0001954) | 1.88324394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.31927376 |
| 2 | TXK | 4.18189185 |
| 3 | TAOK3 | 3.87057279 |
| 4 | RIPK4 | 2.77351061 |
| 5 | MAP3K14 | 2.70246970 |
| 6 | IRAK4 | 2.52890432 |
| 7 | TYK2 | 2.48401963 |
| 8 | IKBKE | 2.45466650 |
| 9 | BLK | 2.40164542 |
| 10 | ITK | 2.27758711 |
| 11 | FES | 2.27638912 |
| 12 | ZAP70 | 2.18346466 |
| 13 | SYK | 2.15107110 |
| 14 | BTK | 2.14320802 |
| 15 | JAK3 | 2.09520164 |
| 16 | GRK6 | 2.02381195 |
| 17 | IKBKB | 1.97832535 |
| 18 | TEC | 1.94966291 |
| 19 | TBK1 | 1.93393508 |
| 20 | KIT | 1.88544359 |
| 21 | CSK | 1.80035876 |
| 22 | JAK1 | 1.79244738 |
| 23 | FRK | 1.68201714 |
| 24 | ERN1 | 1.62990901 |
| 25 | ADRBK2 | 1.58941927 |
| 26 | LCK | 1.56722008 |
| 27 | BMPR2 | 1.51253469 |
| 28 | LYN | 1.46592148 |
| 29 | HCK | 1.45811350 |
| 30 | SIK3 | 1.44385017 |
| 31 | MAP3K13 | 1.40046888 |
| 32 | CSF1R | 1.37507325 |
| 33 | PRKCQ | 1.27423026 |
| 34 | TNK2 | 1.21335316 |
| 35 | MAP2K3 | 1.17430422 |
| 36 | CAMKK2 | 1.14959250 |
| 37 | MARK3 | 1.10497272 |
| 38 | PIK3CG | 1.09679303 |
| 39 | TLK1 | 1.03747597 |
| 40 | MATK | 0.97269305 |
| 41 | NUAK1 | 0.95609342 |
| 42 | MST4 | 0.94030169 |
| 43 | IRAK1 | 0.92373761 |
| 44 | GRK7 | 0.91760130 |
| 45 | JAK2 | 0.91048381 |
| 46 | MAP3K11 | 0.85967868 |
| 47 | TRPM7 | 0.85553689 |
| 48 | TGFBR2 | 0.83968890 |
| 49 | CHUK | 0.82217482 |
| 50 | MAP3K3 | 0.80825102 |
| 51 | NLK | 0.80640652 |
| 52 | MAP2K6 | 0.76358042 |
| 53 | KDR | 0.76001892 |
| 54 | ACVR1B | 0.73084164 |
| 55 | STK10 | 0.72562254 |
| 56 | BCKDK | 0.72560816 |
| 57 | PIM1 | 0.71713251 |
| 58 | EPHB1 | 0.71675627 |
| 59 | TESK2 | 0.68660771 |
| 60 | PTK2B | 0.68381345 |
| 61 | CDK4 | 0.67908118 |
| 62 | SIK2 | 0.65438731 |
| 63 | MAPKAPK3 | 0.65373204 |
| 64 | MAP3K7 | 0.64488169 |
| 65 | MAP4K2 | 0.62915920 |
| 66 | MAPK11 | 0.61496490 |
| 67 | PDK1 | 0.61293183 |
| 68 | WNK4 | 0.60470675 |
| 69 | HIPK2 | 0.60469431 |
| 70 | PRPF4B | 0.60209214 |
| 71 | GRK1 | 0.58676296 |
| 72 | PINK1 | 0.57321001 |
| 73 | FGFR3 | 0.56999390 |
| 74 | MAPK7 | 0.56205151 |
| 75 | CLK1 | 0.55018599 |
| 76 | ABL1 | 0.54780513 |
| 77 | ADRBK1 | 0.54184996 |
| 78 | MAP2K2 | 0.49602128 |
| 79 | FGR | 0.47120991 |
| 80 | FGFR4 | 0.46890541 |
| 81 | CAMKK1 | 0.46531834 |
| 82 | PIM2 | 0.44942757 |
| 83 | CDC42BPA | 0.43861262 |
| 84 | TAOK1 | 0.43082169 |
| 85 | FYN | 0.42579683 |
| 86 | MELK | 0.39488865 |
| 87 | PRKD2 | 0.38723874 |
| 88 | FLT3 | 0.38165161 |
| 89 | IGF1R | 0.36276416 |
| 90 | PASK | 0.35386961 |
| 91 | MAPK12 | 0.34892059 |
| 92 | MAP3K1 | 0.33727744 |
| 93 | BMPR1B | 0.33386846 |
| 94 | MAPK3 | 0.31263621 |
| 95 | PRKCD | 0.30220485 |
| 96 | IRAK3 | 0.29927060 |
| 97 | PIK3CA | 0.29258217 |
| 98 | INSR | 0.29151192 |
| 99 | MAPKAPK2 | 0.29118694 |
| 100 | EPHA3 | 0.24102075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.02020300 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.65345322 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.53450929 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.22267539 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.10826996 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.78049677 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.72515150 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.62180646 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.56617606 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.38386920 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.36207977 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.35839739 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.21209076 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.19338703 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.13971674 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.10376389 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.07653761 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05553631 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97702933 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.94104438 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.90569340 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.77838073 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.65153064 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60134118 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.56490267 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55802146 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.54792053 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53721547 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.45888259 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43762529 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33065342 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27971027 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27386911 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16765802 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.12093946 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10424113 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09069413 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02793495 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.00274441 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00171638 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98667838 |
| 42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98173787 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.90688582 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 0.89332089 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.89189115 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88965981 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.88118806 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85739286 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.79350716 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79317295 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 0.76616193 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.73143817 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71426385 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.67105505 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64055372 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60893950 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57540654 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57064329 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56189008 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.48839464 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47414866 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45143945 |
| 63 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45051284 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44779016 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41951329 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40291553 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38851624 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37916950 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.37776814 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36985096 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34685958 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32732809 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32488692 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32341882 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31899064 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31701390 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31206279 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31121258 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.27990713 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26936994 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26815600 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25975538 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25044833 |
| 84 | Phototransduction_Homo sapiens_hsa04744 | 0.24234937 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.23115111 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21686583 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21087627 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20094162 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.18993431 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18272128 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18252506 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.17080402 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.17001448 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16874644 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16785094 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.16688070 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.15466688 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.15330850 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.13781288 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.11678958 |

